Your browser doesn't support javascript.
loading
Need for additional capacity and improved capability for molecular detection of yellow fever virus in European Expert Laboratories: External Quality Assessment, March 2018.
Domingo, Cristina; Ellerbrok, Heinz; Koopmans, Marion; Nitsche, Andreas; Leitmeyer, Katrin; Charrel, Rémi N; Reusken, Chantal B E M.
Afiliación
  • Domingo C; Highly Pathogenic Viruses (ZBS 1), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, World Health Organization (WHO) Collaborating Centre for Emerging Infections and Biological Threats, Berlin, Germany.
  • Ellerbrok H; Highly Pathogenic Viruses (ZBS 1), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, World Health Organization (WHO) Collaborating Centre for Emerging Infections and Biological Threats, Berlin, Germany.
  • Koopmans M; Department of Viroscience, World Health Organization (WHO) Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research, Erasmus MC, Rotterdam, The Netherlands.
  • Nitsche A; Highly Pathogenic Viruses (ZBS 1), Centre for Biological Threats and Special Pathogens, Robert Koch Institute, World Health Organization (WHO) Collaborating Centre for Emerging Infections and Biological Threats, Berlin, Germany.
  • Leitmeyer K; European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
  • Charrel RN; Institute of Research and Development, Unit of Emerging Viruses (UMR), Faculty of Medicine, Aix Marseille University, Marseille, France.
  • Reusken CBEM; Department of Viroscience, World Health Organization (WHO) Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research, Erasmus MC, Rotterdam, The Netherlands.
Euro Surveill ; 23(28)2018 07.
Article en En | MEDLINE | ID: mdl-30017021
ABSTRACT
An external quality assessment of yellow fever virus (YFV) molecular detection in European laboratories was organised in rapid response to an increase in human cases in Brazil in 2018 with risk of import to Europe. Detection of YFV was assessed among 32 laboratories in 23/31 European Union (EU) and European Economic Area (EEA) countries and two laboratories in one non-EU/EEA country. Adequate capabilities were lacking in 10/23 countries; five did not participate as they lacked implemented assays.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fiebre Amarilla / Virus de la Fiebre Amarilla / Pruebas Serológicas / Reacción en Cadena de la Polimerasa de Transcriptasa Inversa / Técnicas de Diagnóstico Molecular / Laboratorios Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Euro Surveill Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2018 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fiebre Amarilla / Virus de la Fiebre Amarilla / Pruebas Serológicas / Reacción en Cadena de la Polimerasa de Transcriptasa Inversa / Técnicas de Diagnóstico Molecular / Laboratorios Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Euro Surveill Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2018 Tipo del documento: Article País de afiliación: Alemania